
Planet Infinity (PLI) price today
Live PLI chart
Planet Infinity (PLI) price details

Planet Infinity price history
Planet Infinity technical analysis
Planet Infinity (PLI) sentiment
About Planet Infinity
Official links
Social media and community
FAQ
1. What is the current price of Planet Infinity (PLI) in USD?
2. What is the market capitalization of Planet Infinity (PLI)?
3. What is the circulating supply of Planet Infinity (PLI)?
4. What factors influence the price of Planet Infinity (PLI)?
5. Is Planet Infinity (PLI) a good investment?
6. Where can I buy Planet Infinity (PLI)?
7. What are the typical fees when buying Planet Infinity (PLI)?
8. What are some technical indicators used for analyzing Planet Infinity (PLI)?
Currency price converter
Popular
How to buy
Planet Infinity news
Democratic Party's AI Regulation Push Revealed: Plans for Intensive Legislation and Strict Scrutiny of Tech Giants
PFE Stock: Pfizer’s Q3 2026 Earnings, Business Strategy, and Dividend Outlook
PFE is the New York Stock Exchange ticker for Pfizer Inc. In the third quarter of 2026, Pfizer reported revenue of $16.58 billion and adjusted earnings per share of $0.87, both above market expectations. The company raised its full-year revenue outlook to $62 billion–$64 billion and its adjusted EPS guidance to $2.95–$3.05, pointing to stronger performance than previously expected.
Although demand for COVID-related products continues to decline, Pfizer’s non-COVID business is growing. Third-quarter sales reached $720 million for the cancer drug Padcev and $2.52 billion for Eliquis, up 25% year over year. Revenue from newer and acquired products rose 32%. Pfizer is expanding its oncology pipeline, entering the weight-loss treatment market through its acquisition of Metsera, and targeting approximately $9.7 billion in net cost savings by 2029. Cecile Guegan has also taken over as chief financial officer.
Investors are also watching Pfizer’s dividend and legal developments. The company declared a cash dividend of $0.43 per share, with an ex-dividend date of November 6, 2026. Analysts raised some earnings estimates and price targets following the quarterly results. Pfizer also faces ongoing legal scrutiny related to statements about COVID vaccine safety, while its subsidiary Mylan has sued Novo Nordisk over generic-drug patent issues involving Wegovy. Pfizer’s outlook depends on new-product growth, cost savings, patent matters, and litigation developments. This article is for informational purposes only and is not investment advice.
South Korea’s GOPAX halts crypto trading, withdrawals after hacking threat
Bhutan: A royal decree opens the future central bank's reserves in Gelephu to cryptocurrencies
Bhutan equips Gelephu Mindfulness City with a central bank authorized to hold cryptocurrencies in reserve, backed by the kingdom's hydropower mining.
Website
Whitepaper
X(Twitter)











